Insider Stock Trading History of Quay Steven C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Quay Steven C since year 2005. The trader's CIK number is 1008227. At the time of this reporting, Quay Steven C is the President & CEO of Atossa Genetics Inc . (stock ticker symbol ATOS). See this page for all insider trading activities at Atossa Genetics Inc .

Note that in the past QUAY STEVEN C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Quay Steven C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-03-09 ATOS Atossa Genetics Inc Buy 15,000 .37 5,550
2016-02-16 ATOS Atossa Genetics Inc Buy 15,000 .53 7,950
2016-01-19 ATOS Atossa Genetics Inc Buy 50,000 .20 10,000
2013-10-01 ATOS Atossa Genetics Inc Sale 7,265 5.66 41,105
2007-09-27 NSTK Nastech Pharmaceutical Co Inc Sale 5,200 13.57 70,564
2007-07-25 NSTK Nastech Pharmaceutical Co Inc Sale 5,800 12.24 70,963
2007-06-07 NSTK Nastech Pharmaceutical Co Inc Sale 6,400 11.05 70,720
2007-04-18 NSTK Nastech Pharmaceutical Co Inc Sale 5,850 12.04 70,410
2007-02-27 NSTK Nastech Pharmaceutical Co Inc Sale 6,130 11.50 70,519
2007-01-25 NSTK Nastech Pharmaceutical Co Inc Sale 5,250 13.43 70,486
2006-11-15 NSTK Nastech Pharmaceutical Co Inc Sale 3,620 19.56 70,818
2006-10-09 NSTK Nastech Pharmaceutical Co Inc Sale 5,175 15.62 80,807
2006-08-08 NSTK Nastech Pharmaceutical Co Inc Sale 5,820 13.88 80,764
2006-04-25 NSTK Nastech Pharmaceutical Co Inc Sale 5,100 15.75 80,345
2006-04-11 NSTK Nastech Pharmaceutical Co Inc Option Ex 2,667 9.78 26,083
2006-04-11 NSTK Nastech Pharmaceutical Co Inc Sale 2,667 15.83 42,218
2006-03-16 NSTK Nastech Pharmaceutical Co Inc Sale 4,950 16.17 80,041

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Quay Steven C (President & CEO of Atossa Genetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.